Todays Report: Today, Humana Inc. (HUM) Receives Equal Weight Rating from Barclays PLC

Today, Humana Inc. (HUM) Receives Equal Weight Rating from Barclays PLC

Barclays PLC reaffirmed their equal weight rating on shares of Humana Inc. (NYSE:HUM) in a report issued on Friday morning. They currently have a $191.00 price objective on the insurance provider’s stock.

A number of other equities analysts also recently weighed in on HUM. Leerink Swann reaffirmed an outperform rating on shares of Humana in a research note on Tuesday, June 21st. Wolfe Research started coverage on shares of Humana in a research note on Tuesday, June 28th. They issued a market perform rating and a $244.00 target price on the stock. Credit Suisse Group AG reissued a hold rating on shares of Humana in a research note on Tuesday, June 28th. JPMorgan Chase & Co. downgraded shares of Humana from an overweight rating to a neutral rating and dropped their price target for the stock from $196.00 to $150.00 in a research note on Friday, July 8th. Finally, Cantor Fitzgerald reaffirmed a buy rating on shares of Humana in a research note on Saturday, July 9th. Seven analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Humana currently has an average rating of Buy and an average target price of $200.50.

Humana (NYSE:HUM) traded down 0.39% during trading on Friday, hitting $170.15. 143,755 shares of the company’s stock traded hands. Humana has a 12-month low of $150.00 and a 12-month high of $191.65. The stock has a market cap of $25.36 billion, a P/E ratio of 26.14 and a beta of 0.90. The firm’s 50-day moving average price is $175.94 and its 200 day moving average price is $175.74.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The firm had revenue of $14 billion for the quarter, compared to analyst estimates of $13.59 billion. During the same quarter last year, the business earned $1.67 earnings per share. Humana’s revenue was up 2.0% compared to the same quarter last year. Analysts anticipate that Humana will post $9.24 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date is Tuesday, October 11th. Humana’s payout ratio is presently 18.18%.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Virginia Retirement System acquired a new stake in Humana during the first quarter valued at approximately $440,000. NN Investment Partners Holdings N.V. purchased a new stake in shares of Humana during the first quarter worth $3,104,000. Bessemer Group Inc. boosted its stake in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock worth $183,000 after buying an additional 797 shares during the last quarter. Spark Investment Management LLC purchased a new stake in shares of Humana during the first quarter worth $274,000. Finally, Aviva PLC boosted its stake in shares of Humana by 1.9% in the first quarter. Aviva PLC now owns 86,580 shares of the insurance provider’s stock worth $15,840,000 after buying an additional 1,632 shares during the last quarter. 93.27% of the stock is currently owned by hedge funds and other institutional investors.

Humana Company Profile

Related posts

Leave a Comment